Brief: Lumos Pharma To Host Kol Webinar To Discuss Interim Phase 2 Data From Oragrowth Trials In Pghd
29/11/2022 21:15
Nov 29 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA TO HOST KOL WEBINAR TO DISCUSS INTERIM PHASE
2 DATA
FROM ORAGROWTH TRIALS IN PGHD
Source text for Eikon: ID:nGNX7tQsFp
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)